Navigation Links
Neogen shares to be priced Oct. 31

LANSING, Mich., Oct. 30, 2013 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) today announced that a miscommunication between the company and the NASDAQ National Market System has led to the price of Neogen's common stock to remain at pre-dividend levels, contrary to an earlier press release.

The price of Neogen's common stock will be recalculated as of the close of the NASDAQ National Market System today, Oct. 30.

Neogen earlier announced that a 3-for-2 stock split is to be effected in the form of a stock dividend that will be paid in newly issued common stock on Oct. 30, 2013, to shareholders of record as of the close of business on Oct. 15, 2013.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

CONTACT: Steven J. Quinlan
Neogen VP & CFO

SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neogen shares begin post-split trading
2. Neogen reports 18% revenue increase
3. Neogen announces 1st quarter results conference call
4. Neogen launches comprehensive dairy heifer genomic test
5. Neogen announces Bohannon retirement, successor named
6. Neogen launches comprehensive cattle genomic test
7. Neogen reports 27% increase in quarterly net income
8. Neogen launches rapid tests for ractopamine
9. Neogen Corporation Announces 3rd Quarter Results Conference Call
10. Neogen reports 30% increase in quarterly net income
11. Neogen Corporation Announces 1st Quarter Results Conference Call
Post Your Comments:
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... 2016 Andrew D ... Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):